Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 2 hours ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 7 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 7 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 10 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Patent Awarded for DNA Tags on Synthetic Fibers

DNA analysis graphic

A company creating tags similar to bar codes from nucleic acids like DNA received a patent for a process to identify and track synthetic fibers made from wood. . . . → Read More: Patent Awarded for DNA Tags on Synthetic Fibers

Infographic – IBM Leads Again in Patent Awards

Chart: patents awarded in 2018

Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association, this weekend’s infographic on Science & Enterprise. . . . → Read More: Infographic – IBM Leads Again in Patent Awards

Patent Awarded for Engineered T-Cell Cancer Therapy

Human T-cell

An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent. . . . → Read More: Patent Awarded for Engineered T-Cell Cancer Therapy

UC-Berkeley to Get New Crispr Patent

U.S. Patent and Trademark Office

University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Company Formed to Advance Sickle Cell Gene Therapy

Sickle cell illustration

A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders. . . . → Read More: Company Formed to Advance Sickle Cell Gene Therapy

Patents Awarded for Stem Cell Heart Disease Technologies

U.S. Patent and Trademark Office

A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

Ultra-Sensitive Nanotech Robot Skin Receives Patent

ultra-sensitive robot skin

Inventors of a system of sensors packaged in a thin film received a patent for their work that enables robotic devices to better sense conditions in the nearby environment. . . . → Read More: Ultra-Sensitive Nanotech Robot Skin Receives Patent

UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Editing DNA

University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent